FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017606008> ?p ?o ?g. }

• W2017606008 abstract "TP10, a potent inhibitor of complement activation during cardiopulmonary bypass (CPB) has been shown to significantly reduce the incidence of death and myocardial infarction (MI) in high-risk male patients undergoing cardiac surgery. However, the effect of TP10 in females was undefined because of the limited number of females studied. To examine the possibility of a gender effect, this phase 2 multi-center trial was undertaken to determine whether TP10 would also limit ischemic damage in a larger sample size of high-risk females undergoing cardiac surgery on cardiopulmonary bypass (CPB).This prospective, double-blind, placebo-controlled, multi-center trial involved 297 high-risk (urgent surgery, CABG + Valve, reoperations, ejection fraction <30%) female patients randomized to receive a 5 mg/kg dose of TP10 (n=150) or placebo (n=147) as a 30-minute intravenous infusion before surgery. The primary end point was the incidence of death or MI at 28 days after surgery. Complement activation was assessed by levels of CH50 and SC5b-9 during and after CPB. TP10 was well tolerated and there were no differences in the safety profiles of the 2 groups. Although TP10 effectively suppressed complement activation (at 2 hours after CPB CH50 (mean+SD % change from baseline) 50+/-17% placebo versus 4+/-14% TP10; P=0.0001; SC5b-9 (ng/mL) 917+/-1067 placebo versus 204+/-79 TP10; P=0.0001), there was no difference in the primary end point between the groups (17% placebo versus 21% TP10; P=0.2550).The benefits of TP10 appear to be gender-related. and mechanisms other than complement activation may be responsible for myocardial injury in high-risk female patients during cardiac surgery on CPB." @default.
• W2017606008 created "2016-06-24" @default.
• W2017606008 creator A5000595541 @default.
• W2017606008 creator A5001467516 @default.
• W2017606008 creator A5014110421 @default.
• W2017606008 creator A5025021235 @default.
• W2017606008 creator A5027333928 @default.
• W2017606008 creator A5050069755 @default.
• W2017606008 creator A5053164982 @default.
• W2017606008 creator A5055067855 @default.
• W2017606008 date "2007-09-11" @default.
• W2017606008 modified "2023-10-16" @default.
• W2017606008 title "Beneficial Effects of Complement Inhibition With Soluble Complement Receptor 1 (TP10) During Cardiac Surgery" @default.
• W2017606008 cites W1963684082 @default.
• W2017606008 cites W2001073626 @default.
• W2017606008 cites W2008904760 @default.
• W2017606008 cites W2041156861 @default.
• W2017606008 cites W2043440826 @default.
• W2017606008 cites W2052440346 @default.
• W2017606008 cites W2052667465 @default.
• W2017606008 cites W2071177681 @default.
• W2017606008 cites W2074745934 @default.
• W2017606008 cites W2086635894 @default.
• W2017606008 cites W2090639306 @default.
• W2017606008 cites W2092998122 @default.
• W2017606008 cites W2099739614 @default.
• W2017606008 cites W2104502908 @default.
• W2017606008 cites W2116638495 @default.
• W2017606008 cites W2122865912 @default.
• W2017606008 cites W2163533907 @default.
• W2017606008 cites W2169274423 @default.
• W2017606008 cites W2184810220 @default.
• W2017606008 cites W2419388105 @default.
• W2017606008 cites W4293085726 @default.
• W2017606008 cites W923764892 @default.
• W2017606008 doi "https://doi.org/10.1161/circulationaha.106.677914" @default.
• W2017606008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17846331" @default.
• W2017606008 hasPublicationYear "2007" @default.
• W2017606008 type Work @default.
• W2017606008 sameAs 2017606008 @default.
• W2017606008 citedByCount "19" @default.
• W2017606008 countsByYear W20176060082012 @default.
• W2017606008 countsByYear W20176060082013 @default.
• W2017606008 countsByYear W20176060082014 @default.
• W2017606008 countsByYear W20176060082015 @default.
• W2017606008 countsByYear W20176060082016 @default.
• W2017606008 countsByYear W20176060082017 @default.
• W2017606008 countsByYear W20176060082019 @default.
• W2017606008 countsByYear W20176060082020 @default.
• W2017606008 countsByYear W20176060082021 @default.
• W2017606008 countsByYear W20176060082022 @default.
• W2017606008 crossrefType "journal-article" @default.
• W2017606008 hasAuthorship W2017606008A5000595541 @default.
• W2017606008 hasAuthorship W2017606008A5001467516 @default.
• W2017606008 hasAuthorship W2017606008A5014110421 @default.
• W2017606008 hasAuthorship W2017606008A5025021235 @default.
• W2017606008 hasAuthorship W2017606008A5027333928 @default.
• W2017606008 hasAuthorship W2017606008A5050069755 @default.
• W2017606008 hasAuthorship W2017606008A5053164982 @default.
• W2017606008 hasAuthorship W2017606008A5055067855 @default.
• W2017606008 hasBestOaLocation W20176060081 @default.
• W2017606008 hasConcept C126322002 @default.
• W2017606008 hasConcept C141071460 @default.
• W2017606008 hasConcept C142724271 @default.
• W2017606008 hasConcept C164705383 @default.
• W2017606008 hasConcept C168563851 @default.
• W2017606008 hasConcept C203092338 @default.
• W2017606008 hasConcept C204787440 @default.
• W2017606008 hasConcept C27081682 @default.
• W2017606008 hasConcept C2778198053 @default.
• W2017606008 hasConcept C2778789114 @default.
• W2017606008 hasConcept C2778881276 @default.
• W2017606008 hasConcept C42219234 @default.
• W2017606008 hasConcept C71924100 @default.
• W2017606008 hasConcept C78085059 @default.
• W2017606008 hasConceptScore W2017606008C126322002 @default.
• W2017606008 hasConceptScore W2017606008C141071460 @default.
• W2017606008 hasConceptScore W2017606008C142724271 @default.
• W2017606008 hasConceptScore W2017606008C164705383 @default.
• W2017606008 hasConceptScore W2017606008C168563851 @default.
• W2017606008 hasConceptScore W2017606008C203092338 @default.
• W2017606008 hasConceptScore W2017606008C204787440 @default.
• W2017606008 hasConceptScore W2017606008C27081682 @default.
• W2017606008 hasConceptScore W2017606008C2778198053 @default.
• W2017606008 hasConceptScore W2017606008C2778789114 @default.
• W2017606008 hasConceptScore W2017606008C2778881276 @default.
• W2017606008 hasConceptScore W2017606008C42219234 @default.
• W2017606008 hasConceptScore W2017606008C71924100 @default.
• W2017606008 hasConceptScore W2017606008C78085059 @default.
• W2017606008 hasIssue "11_supplement" @default.
• W2017606008 hasLocation W20176060081 @default.
• W2017606008 hasLocation W20176060082 @default.
• W2017606008 hasOpenAccess W2017606008 @default.
• W2017606008 hasPrimaryLocation W20176060081 @default.
• W2017606008 hasRelatedWork W1979249554 @default.
• W2017606008 hasRelatedWork W1980391494 @default.
• W2017606008 hasRelatedWork W2003938723 @default.
• W2017606008 hasRelatedWork W2047967234 @default.
• W2017606008 hasRelatedWork W2052863171 @default.
• W2017606008 hasRelatedWork W2118496982 @default.

• next